EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against OvaScience, Inc. - OVAS

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of OvaScience, Inc. (“OvaScience”) (NASDAQ:OVAS) resulting from allegations that OvaScience may have issued materially misleading business information to the investing public.

This investigation concerns whether OvaScience made materially untrue and misleading statements and omitted material information due to OvaScience’s failure to disclose that the OvaScience’s AUGMENT procedure did not attain a substantial success rate of clinical pregnancies compared to former rates attained without OvaScience’s AUGMENT procedure.

Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by OvaScience investors. If you purchased shares of OvaScience, please visit the firm’s website at http://rosenlegal.com/cases-820.html for more information. You may also contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com or kchan@rosenlegal.com.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Attorney Advertising. Prior results do not guarantee a similar outcome.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160125006265/en/